Not available outside of the UK & Ireland.
Biochem/physiol Actions
UCM710 is a dual inhibitor of fatty acid amide hydrolase (FAAH) and A/β hydrolase domain 6 (ABHD6) the enzymes that hydrolyze endocannabinoids. UCM710 augments both N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) levels in neurons. UCM710 does not inhibit monoacylglycerol lipase (MAGL).
Features and Benefits
This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: